SOLVE Chemistry has raised £4 million in a seed funding round led by XTX Ventures, with participation from SuperSeed, Creator Fund, and climate fund Endgame Capital. The London-based chemistry startup supports pharmaceutical and agrochemical manufacturers in bringing products to market faster, more sustainably, and at lower cost.
Designing chemical production lines is time-consuming and expensive, delaying drugs and agrochemicals from reaching patients and customers while exposing manufacturers to changing market conditions. SOLVE Chemistry addresses this by scaling chemical production more quickly, using ultra-high-throughput data collection hardware at its London lab to gather accurate reaction data significantly faster than traditional experimentation and training predictive models to determine optimal manufacturing routes.
SOLVE Chemistry is a spinout from Imperial College London founded by Dr Linden Schrecker and Dr Jose Pablo Folch, originating from Imperial research sponsored by BASF. The company spun out from Imperial in April 2024 and began by renting lab space at Imperial’s White City Deep Tech Campus before expanding into larger facilities at Scale Space.
The funding will enable SOLVE Chemistry to quadruple production capacity, expand its team, and build new capabilities to deliver more value to pharmaceutical and agrochemical manufacturers as they scale up their processes.
